Table 2.

Clinical information of two independent validation cohorts

Parameters	LccRCC (n = 97) (%)	AccRCC (n = 60) (%)
Sex
Male	65 (67)	46 (77)
Female	32 (33)	14 (23)
Age
20–45	20 (21)	5 (8)
46–59	32 (33)	24 (40)
60–69	33 (34)	21 (35)
70–85	12 (12)	10 (17)
WHO/ISUP
I	21 (22)	3 (5)
II	55 (56)	20 (33)
III	21 (22)	27 (45)
IV	0 (0)	10 (17)
Maximum diameter (cm)
0–4	58 (60)	11 (18)
4–7	36 (37)	26 (43)
7–10	2 (2)	15 (25)
10–15	1 (1)	8 (14)
Necrosis
Yes	1 (1)	23 (38)
No	96 (99)	37 (62)

Parameters	LccRCC (n = 24) (%)	AccRCC (n = 32) (%)
Sex
Male	20 (83)	28 (88)
Female	4 (17)	4 (12)
Age
20–45	0 (0)	3 (9)
46–59	9 (38)	6 (19)
60–69	12 (50)	15 (47)
70–85	3 (12)	8 (25)
WHO/ISUP
I	4 (17)	1 (3)
II	10 (42)	13 (41)
III	7 (29)	14 (44)
IV	3 (12)	4 (12)
Maximum diameter (cm)
0–4	7 (29)	7 (22)
4–7	13 (54)	15 (47)
7–10	4 (17)	6 (19)
10–15	0 (0)	4 (12)
Necrosis
Yes	3 (12)	8 (25)
No	21 (88)	24 (75)